To investigate whether the difference in composition of CD16– NK cells between PB and SF could in part be explained by changes in the levels of ADAM17 (given its role in CD16 receptor shedding), we measured the levels of soluble ADAM17 by ELISA in paired serum and SF samples from patients with active RA. The gene discussed is ADAM17; the disease is rheumatoid arthritis.